Mutations in the MAPT gene have been linked to various neurodegenerative conditions, including Alzheimer’s disease (AD), frontotemporal dementia, cortico-basal degeneration, and progressive supranuclear palsy [23]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.